Market overview
The global microwave ablation devices market is worth USD 1.2 bn in 2026 and is forecast to reach USD 2.9 bn by 2036, growing at a 9.5% CAGR. China is the largest country market and Disposable antennas and probes is the largest by product segment.
| Scope | Systems that destroy tumours with microwave energy: generators, antennas and disposable probes for liver, lung, kidney and thyroid ablation. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 1.1 bn |
| Value 2026 | USD 1.2 bn |
| Value 2036 | USD 2.9 bn |
| CAGR 2026-2036 | 9.5% |
| Volume 2026 | 490 thousand procedures |
| Volume 2036 | 1,100 thousand procedures |
| Average price 2026 | USD 2,357 per procedure |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Microwave Ablation Devices market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 1.2 bn |
| 2027 | USD 1.3 bn |
| 2028 | USD 1.4 bn |
| 2029 | USD 1.5 bn |
| 2030 | USD 1.7 bn |
| 2031 | USD 1.8 bn |
| 2032 | USD 2.0 bn |
| 2033 | USD 2.2 bn |
| 2034 | USD 2.4 bn |
| 2035 | USD 2.6 bn |
| 2036 | USD 2.9 bn |
Microwave Ablation Devices market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Disposable antennas and probes | 62.0% | 65.5% | USD 716 mn | 10.1% |
| Generators | 25.0% | 23.0% | USD 289 mn | 8.6% |
| Accessories and services | 13.0% | 11.4% | USD 150 mn | 8.1% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Liver | 42.0% | 39.4% | USD 485 mn | 8.8% |
| Lung | 18.0% | 19.4% | USD 208 mn | 10.3% |
| Kidney | 10.0% | 10.8% | USD 116 mn | 10.3% |
| Thyroid and bone | 12.0% | 13.5% | USD 139 mn | 10.8% |
| Other | 18.0% | 16.9% | USD 208 mn | 8.8% |
By power source
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Microwave generators | 38.0% | 36.0% | USD 439 mn | 8.9% |
| Antennas and probes | 34.0% | 33.0% | USD 393 mn | 9.2% |
| Cooling and delivery accessories | 28.0% | 31.0% | USD 323 mn | 10.6% |
By tissue target
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Liver | 36.0% | 34.0% | USD 416 mn | 8.9% |
| Lung | 20.0% | 21.0% | USD 231 mn | 10.0% |
| Kidney | 12.0% | 12.0% | USD 139 mn | 9.5% |
| Thyroid and bone | 18.0% | 17.0% | USD 208 mn | 8.9% |
| Others combined | 14.0% | 16.0% | USD 162 mn | 11.0% |
By approach
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Percutaneous | 62.0% | 58.0% | USD 716 mn | 8.8% |
| Laparoscopic | 18.0% | 19.0% | USD 208 mn | 10.1% |
| Open surgery | 8.0% | 7.0% | USD 92 mn | 8.1% |
| Endoscopic and image-guided | 12.0% | 16.0% | USD 139 mn | 12.7% |
Top 25 countries for microwave ablation devices by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 81.5% of 2026 revenue and the 25 countries below together hold 95.2%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | China | USD 277 mn | 24.0% | USD 890 mn | 12.4% |
| 2 | United States | USD 254 mn | 22.0% | USD 544 mn | 7.9% |
| 3 | Japan | USD 92 mn | 8.0% | USD 189 mn | 7.4% |
| 4 | South Korea | USD 69 mn | 6.0% | USD 169 mn | 9.3% |
| 5 | Germany | USD 58 mn | 5.0% | USD 117 mn | 7.3% |
| 6 | Italy | USD 46 mn | 4.0% | USD 97 mn | 7.7% |
| 7 | France | USD 46 mn | 4.0% | USD 97 mn | 7.7% |
| 8 | United Kingdom | USD 35 mn | 3.0% | USD 74 mn | 7.9% |
| 9 | India | USD 35 mn | 3.0% | USD 112 mn | 12.4% |
| 10 | Brazil | USD 29 mn | 2.5% | USD 72 mn | 9.5% |
| 11 | Spain | USD 24 mn | 2.1% | USD 57 mn | 8.9% |
| 12 | Canada | USD 22 mn | 1.9% | USD 51 mn | 8.9% |
| 13 | Netherlands | USD 19 mn | 1.6% | USD 44 mn | 8.9% |
| 14 | Australia | USD 16 mn | 1.4% | USD 38 mn | 8.9% |
| 15 | Turkey | USD 14 mn | 1.2% | USD 32 mn | 8.8% |
| 16 | Taiwan | USD 11 mn | 1.0% | USD 26 mn | 8.8% |
| 17 | Thailand | USD 9.8 mn | 0.8% | USD 23 mn | 9.0% |
| 18 | Mexico | USD 8.8 mn | 0.8% | USD 21 mn | 8.9% |
| 19 | Russia | USD 7.0 mn | 0.6% | USD 17 mn | 8.9% |
| 20 | Poland | USD 5.8 mn | 0.5% | USD 14 mn | 9.1% |
| 21 | Vietnam | USD 5.4 mn | 0.5% | USD 13 mn | 8.8% |
| 22 | Indonesia | USD 4.8 mn | 0.4% | USD 11 mn | 8.7% |
| 23 | Saudi Arabia | USD 4.0 mn | 0.3% | USD 9.4 mn | 8.9% |
| 24 | Egypt | USD 3.6 mn | 0.3% | USD 8.3 mn | 8.8% |
| 25 | Sweden | USD 3.1 mn | 0.3% | USD 7.2 mn | 8.7% |
| Rest of world | USD 55 mn | 4.8% | USD 130 mn | 8.9% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Medtronic
- Johnson & Johnson MedTech
- AngioDynamics
Group 2: Regional and specialist players
- Nanjing ECO Microwave
- Canyon Medical
- Mermaid Medical
- HS Hospital Service
Group 3: Emerging and niche players
- Emblation
- MedWaves
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the microwave ablation devices market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.5% is calculated from the resulting values.
The market is divided by product, by application, by power source, by tissue target, by approach. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the microwave ablation devices market?
The global microwave ablation devices market is estimated at USD 1.1 bn in 2025 and USD 1.2 bn in 2026.
How fast will the microwave ablation devices market grow?
It is forecast to reach USD 2.9 bn by 2036, a compound annual growth rate of 9.5% from 2026, an increase of USD 1.7 bn.
Which country is the largest market for microwave ablation devices?
China is the largest market by revenue at USD 277 mn in 2026, 24.0% of the global total. The three largest countries together hold 54.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 12.4% a year from 2026 to 2036.
Which microwave ablation devices segment is largest?
In the by product split, Disposable antennas and probes is the largest segment with 62.0% of 2026 revenue.
Who are the leading microwave ablation devices companies?
Global leaders include Medtronic, Johnson & Johnson MedTech, AngioDynamics.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Tablet PressUSD 1.2 bn · 5.5% CAGR
- Catheter-Based Pulmonary Embolism ThrombectomyUSD 1.1 bn · 12.0% CAGR
- Wearable InjectorUSD 1.1 bn · 13.0% CAGR
- AI-Accelerated Nonclinical Drug TestingUSD 1.2 bn · 14.0% CAGR
- Manufacturing on Demand for MedicalUSD 1.2 bn · 10.0% CAGR
- Advanced Implantable Electrode NeurotechnologyUSD 1.2 bn · 7.8% CAGR
- Robotic Rehab ToolsUSD 1.2 bn · 12.0% CAGR
- Multi-Organ Transplant MonitoringUSD 1.1 bn · 9.0% CAGR
← Microsphere Drug Delivery Mixed Reality Navigation Platforms →